Advertisement

Platelet Aggregation Inhibition Activity of Placental Brush Border Membrane

  • Hideaki Iioka
  • I. Moriyama
  • S. Akada
  • M. Akasaki
  • K. Nabuchi
  • H. Hisanaga
  • K. Morimoto
  • M. Ichijo
Conference paper

Abstract

Thrombus occurs frequently in the placental chorionic lumen of patients with Pre-ecclampsia (EPH) gestosis, and participation of platelets is suggested in the pathology of the diseases. In the placental tissues, there is an antiplatelet aggregating factor which plays an important role in the maintenance of microcirculation in the placenta. The brush border membrane of the placental chorioepithe-lium plays the part of the vasoendothelium as it is the point of direct contact with the maternal blood flow in the chorionic lumen. It has already been confirmed that a strong inhibitory action on platelet aggregation is present in the vasoendothelium, and its main active mechanism is shown to be prostacyclin (PG I2) and ADP degrading by an ADPase-like activity which exists in edothelial membrane. Thus, it is quite possible that some inhibitory activity on platelet aggregation exists in the brush border membrane of placental chorioepithelium. We, therefore, investigated the presence of such an inhibitory activity on platelet aggregation as well as its properties using a fraction of the brush border membrane.

Keywords

Platelet Aggregation Platelet Rich Plasma Brush Border Membrane Brush Border Membrane Vesicle Final Protein Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ioka H, Moriyama SI, Icijo M (1985) The study on placental phosphate transport mechanism (using human placental brush border membrane vesicles). Acta Obst Gynaecol Jpn 37: 2675Google Scholar
  2. 2.
    Lowry OH, Rosebrough NJ, Faro AL, Rondell RJ (1951) Protein measurement with the folin Phenol reagent. J Biol Chem 193: 265PubMedGoogle Scholar
  3. 3.
    Born GVR, Gross MJ (1963) The aggregation of blood platelet. J Physiol 168: 178PubMedGoogle Scholar
  4. 4.
    Duchesne MJD, Dao HT, Chavis C, Crastes A (1982) The human placental anti-aggregating factor is neither prostacyclin nor a prostacyclin metabolite. Prostaglandins 24: 701CrossRefGoogle Scholar
  5. 5.
    Glassgow JG, Scade R, Pitlick FA (1978) Evidence that ADP hydrolysis by human cell is related to thrombogenic potential. Thromb Res 13: 255CrossRefGoogle Scholar
  6. 6.
    Hutton RA, Dandona P, Chow FPR, Craft IL (1980) Inhibition of platelet aggregation by placental extracts. Thromb Res 17: 465PubMedCrossRefGoogle Scholar
  7. 7.
    Mochizuki O (1987) Studies on platelet aggregation inhibitor isolated from the human placenta. Acta Obst Gynaecol Jpn 39: 1729Google Scholar

Copyright information

© Springer Japan 1991

Authors and Affiliations

  • Hideaki Iioka
    • 1
  • I. Moriyama
    • 1
  • S. Akada
    • 1
  • M. Akasaki
    • 1
  • K. Nabuchi
    • 1
  • H. Hisanaga
    • 1
  • K. Morimoto
    • 1
  • M. Ichijo
    • 1
  1. 1.Department of Obstetrics and GynecologyNara Medical UniversityKashihara City, Nara, 634Japan

Personalised recommendations